Results 181 to 190 of about 9,343 (245)

Inadequate pediatric reference ranges impede the diagnosis of X-linked hypophosphatemia and hypophosphatasia in Austria. [PDF]

Wien Klin Wochenschr
Steininger J, Jablonska M, Sagmeister S, Mindler G, Raimann A.   +4 more
europepmc   +1 more source

Real-world characteristics & disease history of patients with X-linked hypophosphatemia before treatment with burosumab. [PDF]

Arch Osteoporos
Dahir KM, Li Z, Heerssen HM, Noman A, Kim J, Zhao Y, Imel EA.   +6 more
europepmc   +1 more source

Factors associated with impaired physical functionality in X-linked hypophosphatemia. [PDF]

JBMR Plus
Ivanovic-Zuvic D, Madison A, Jiménez M, Oyanadel ML, Gattini N, Guzmán C, Cifré M, Silvestre R, García C, Contreras O, Collins MT, Florenzano P.   +11 more
europepmc   +1 more source

Epidemiological analysis to identify predictors of X-linked hypophosphatemia (XLH) diagnosis in an Italian pediatric population: the EPIX project [PDF]

Salvatore Crisafulli, Ylenia Ingrasciotta, Giacomo Vitturi, Andrea Fontana, Luca L’Abbate, Ylenia Alessi, Francesco Ferraù, Luigi Cantarutti, Debora Lazzerini, Salvatore Cannavò, Gianluca Trifirò   +10 more
openalex   +1 more source

Switching from active vitamin D and phosphate supplementation to burosumab significantly corrects lower limb malalignment in pediatric X-linked hypophosphatemia. [PDF]

J Bone Miner Res
Ward LM, Imel EA, Frumberg D, Dilworth L, Siener C, Chen Z, Krolczyk S, Carpenter TO, XLH Disease Monitoring Program Investigators .   +8 more
europepmc   +1 more source

The Burden of Adult X-Linked Hypophosphatemia on Carers and Family Members: A Mixed-Methods Study. [PDF]

J Health Econ Outcomes Res
Matter E, Lawrence C, Gardiner O, Hayes V, Logan G, Johnson B, Lloyd A.   +6 more
europepmc   +1 more source

Characterization of adult patients with X-linked hypophosphatemia at a specialized center in Buenos Aires, Argentina. [PDF]

Arch Endocrinol Metab
Giacoia E, Schiró LM, Martínez T, Balonga MC, Plantalech L.   +4 more
europepmc   +1 more source

Elevated Bone Remodeling Markers of CTX and P1NP in Addition to Sclerostin in Patients with X-linked Hypophosphatemia: A Cross-Sectional Controlled Study

, 2019
Stinus Hansen, Vikram Vinod Shanbhogue, Niklas Rye Jørgensen, Signe Sparre Beck‐Nielsen   +3 more
openalex   +2 more sources

Double burdened yet resilient: quality of life of caregivers of people with X-linked hypophosphatemia. [PDF]

JBMR Plus
Pinedo-Villanueva R, Njuki N, Sanchez-Santos MT, Javaid MK.   +3 more
europepmc   +1 more source

Proof-of-principle for enhanced dentoalveolar mineralization using exogenous tissue-nonspecific alkaline phosphatase in the <i>Hyp</i> mouse model of X-linked hypophosphatemia. [PDF]

JBMR Plus
Phanrungsuwan A, Donnelly B, Mohamed FF, Sawangsri K, Belgya K, Kolli TN, Kim J, Kim DG, de Oliveira FA, Liu ES, Millán JL, Foster BL.   +11 more
europepmc   +1 more source